Related Experiment Video

Updated: Aug 23, 2026

Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension
09:23

Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension

Published on: February 11, 2017

PDGF and cardiovascular disease

Elaine W Raines1

  • 1Department of Pathology, Harborview Medical Center, University of Washington, Box 359675, 325 9th Avenue, Seattle, WA 98104, USA. ewraines@u.washington.edu

Cytokine & Growth Factor Reviews
|June 23, 2004
PubMed

Insights

Platelet-derived growth factor (PDGF) drives smooth muscle cell (SMC) proliferation and migration, crucial processes in atherosclerosis development and cardiovascular disease. Inhibiting PDGF shows promise for treating these conditions.

Area of Science:

  • Cardiovascular Biology
  • Cellular and Molecular Medicine
  • Vascular Biology

Background:

  • Smooth muscle cells (SMCs) migrate and proliferate during atherosclerosis, contributing to arterial lesion development.
  • Inflammatory factors stimulate SMC migration from the media into the intima, a key event in lesion formation.
  • Platelet-derived growth factor (PDGF) is a serum factor known to stimulate SMC proliferation.

Purpose of the Study:

  • To investigate the role of Platelet-derived growth factor (PDGF) in smooth muscle cell (SMC) proliferation and migration.
  • To evaluate the contribution of PDGF to the pathogenesis of atherosclerosis and cardiovascular disease.

Main Methods:

  • Identification of serum factors stimulating SMC proliferation.
  • Utilizing genetic manipulations in vascular cells.
  • Employing various inhibitory strategies to block PDGF activity.
  • In vivo studies to assess PDGF functions.

Main Results:

  • PDGF was identified as a key serum factor stimulating SMC proliferation.
  • Genetic and inhibitory strategies provided strong evidence for PDGF's role in SMC migration into the neointima after injury.
  • PDGF plays a prominent role in the pathogenesis of atherosclerosis.
  • In vivo studies revealed additional functions of PDGF in cardiovascular disease.

Conclusions:

  • PDGF is a critical mediator of SMC proliferation and migration in the context of vascular injury and atherosclerosis.
  • Targeting PDGF may offer therapeutic strategies for cardiovascular diseases.
  • Further research into PDGF's in vivo activities is warranted for a comprehensive understanding of its role in cardiovascular pathology.

More Related Videos

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity: